-

Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, granted a total of 44,500 non-qualified inducement stock options to six employees. These awards were approved by the Compensation Committee of Cutera’s Board of Directors.

The stock options have an exercise price of $2.23, equal to the closing price of Cutera common stock on the grant date of May 13, 2024. A quantity of 25% shall vest annually, and 1/48 of the grant total shall vest each month thereafter, subject to continued employment, for a total of 29,500 stock options granted to five employees. A quantity of 33% shall vest annually, and 1/36 of the grant total shall vest each month thereafter, subject to continued employment, for a total of 15,000 stock options granted to one employee.

Each inducement award is subject to the terms of the Cutera, Inc. 2023 Inducement Equity Incentive Plan and related forms of agreements and were granted as inducements material to these employees to enter into employment with Cutera in accordance with Nasdaq Listing Rule 5635(c)(4).

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Contacts

Cutera, Inc.
Shelby Eckerman
VP, Finance
415-657-5500
IR@cutera.com

Cutera, Inc.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Taylor Harris
Employees: 450
Organization: PUB
Revenues: $252 million (2022)
Net Income: NM (2022)

Release Versions

Contacts

Cutera, Inc.
Shelby Eckerman
VP, Finance
415-657-5500
IR@cutera.com

More News From Cutera, Inc.

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...
Back to Newsroom